Hepion Pharmaceuticals files Form 3 as Black Global 5 reports beneficial ownership stake

PUBT · 1d ago
Hepion Pharmaceuticals files Form 3 as Black Global 5 reports beneficial ownership stake
  • Hepion Pharmaceuticals Form 3 showed Black Global 5 LLC reporting beneficial ownership as a 10% owner, tied to an Aug. 3 event.
  • Reported indirect ownership of 10 million common shares.
  • Reported direct warrants for 10 million common shares, exercisable Aug. 3, expiring Aug. 3, 2031, with a $0.06 exercise price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hepion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036644), on August 07, 2026, and is solely responsible for the information contained therein.